Page results
-
Complex travel appointments are available through NHS referral or private pay. Please note that an NHS referral is only valid in certain cases.
-
The Central Venous Access Device team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
Dr Tyagi is a consultant neuropsychiatrist with a special interest in Tourette's syndrome and obesessive compulsive disorders (OCD)
-
The UK Chagas Hub brings together healthcare professionals, researchers, advocates and members of the Latin American community to tackle Chagas disease in the UK and contribute to global efforts to eliminate the disease.
-
UCLH is a specialist centre for the treatment of urological cancers.
-
The head and neck speech and language therapy team provide a highly specialist service to both inpatients and outpatients who may experience difficulty swallowing or speaking following treatment for head and neck cancer.
-
The heart failure service provides comprehensive care for patients with heart failure.
-
The rapid access chest pain clinic provides a quick and early specialist cardiology assessment for patients who need urgent assessment.
-
This page, written by the Physiotherapy Services at the Royal London Hospital for Integrated Medicine, is intended for patients (or their family or carers) who have been referred to the clinic.
File results
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0244 - IT systems for digital dictation, speech recognition, outsourced transcription, video consultation and health information systems
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023